Back
Surgery Partners Vs. Novo Nordisk AS Industry Stock Comparison
Sell
38
SGRY
Surgery Partners
Last Price:
$20.82
Seasonality Move:
5.45%
Sell
25
NVO
Novo Nordisk AS
Last Price:
$86.09
Seasonality Move:
6.68%
Sell
38
Surgery Partners (SGRY)
is a Sell
Is Surgery Partners a Buy, Sell or Hold?
-
The current Surgery Partners [SGRY] share price is $21.23. The Score for SGRY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
SGRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $85.64. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SGRY Stock Price Chart
What is Surgery Partners's stock price today?
-
The Surgery Partners share price today is $21.23Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SGRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.64Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
SGRY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.73 | Sell |
Relative Strength Index (14 RSI): | 45.77 | Sell |
Chaikin Money Flow: | 623578 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.39 - 21.89) | Buy |
Bollinger Bands (100): | (22.91 - 32.03) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.06 | Sell |
Relative Strength Index (14 RSI): | 31.71 | Sell |
Chaikin Money Flow: | 6521757 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.72 - 109.1) | Sell |
Bollinger Bands (100): | (99.51 - 129.55) | Sell |
SGRY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.93 | Buy |
20-day SMA: | 20.87 | Buy |
50-day SMA: | 23.79 | Sell |
200-day SMA: | 27.01 | Sell |
8-day EMA: | 20.95 | Buy |
20-day EMA: | 21.33 | Sell |
50-day EMA: | 23.45 | Sell |
200-day EMA: | 27.2 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.04 | Sell |
20-day SMA: | 94.95 | Sell |
50-day SMA: | 102.54 | Sell |
200-day SMA: | 123.74 | Sell |
8-day EMA: | 86.81 | Sell |
20-day EMA: | 92.64 | Sell |
50-day EMA: | 101.62 | Sell |
200-day EMA: | 114.8 | Sell |
Surgery Partners Earnings Growth & SGRY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.27 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.54 per share.
Surgery Partners Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |